Tariff threats from the US are colliding with India’s export surge, and that clash is putting a fresh spotlight on large-cap ...
Get latest articles and stories on India at LatestLY. Dr M Srinivas, Member (Health), NITI Aayog, emphasised the importance of academia-Industry partnership while addressing the 8th CII Pharma and ...
It’s a beautiful example of Italian design and Indian craftsmanship coming together."International luxury houses have long ...
Asianet Newsable on MSN
Major regulatory reforms in pharma coming in 1-2 months: Govt
At the 8th CII Pharma Summit, leaders called for academia-industry partnerships and increased R&D investment. The government announced major regulatory reforms are expected within two months to boost ...
Sep 09, 2026, 7:33 PM IST Biocon - Communication Regarding Remittance Of Final Dividend For The FY 2025-26 Sep 08, 2026, 9:33 PM IST Biocon - Announcement under Regulation 30 (LODR)-Analyst / Investor ...
Cupid could see $52 million passive inflows if included in FSTE All Cap index. Urban Company, Pine Labs and Anthem ...
Adani Group stocks rally on September 18 as Adani Total Gas gains 12%. Check Adani share prices, Jefferies targets and the ₹9,825 crore AAHL fundraise.
Key Highlights: [1] Strong programme governance is critical to accelerate innovation, enabling clear accountability, ...
[8] Stronger collaboration between GCCs, pharma companies, startups, academia and institutions such as IITs and IISc can ...
At the CII Pharma & Lifesciences Summit 2026, industry and government leaders put regulatory reform, biopharma innovation and ...
At a New Delhi summit, Dr M Srinivas of NITI Aayog urged academia-industry partnerships and greater R&D investment to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results